Key statistics
On Thursday, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (6990:HKG.HS) closed at 165.60, -26.01% below its 52-week high of 223.80, set on Oct 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 165.10 |
---|---|
High | 170.10 |
Low | 161.60 |
Bid | 165.00 |
Offer | 165.60 |
Previous close | 167.10 |
Average volume | 297.56k |
---|---|
Shares outstanding | 222.84m |
Free float | 134.28m |
P/E (TTM) | -- |
Market cap | 37.24bn HKD |
EPS (TTM) | -1.11 HKD |
Data delayed at least 15 minutes, as of Nov 14 2024 08:08 GMT.
More ▼
Press releases
- Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) Third NDA Accepted by NMPA, locally advanced or metastatic EGFR-mutant NSCLC
- Multiple Study Results of Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) at 2024 CSCO Congress
- Three Study Results Abstracts From Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) At 2024 ESMO Released Today
- Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) Second NDA Accepted by NPMA, locally advanced or metastatic EGFR-mutant NSCLC